Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 47,152 shares at $51.83 ($2.5M) on 2019-01-23, disclosed to the SEC on 2019-01-24.
Scheduled sale ($2.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.93 | 26,450 | $1.4M | 55.9% |
| 2 | $52.42 | 3,550 | $186K | 7.6% |
| 3 | $51.83 | 702 | $36K | 1.5% |
| 4 | $52.37 | 12,975 | $680K | 27.6% |
| 5 | $52.59 | 1,390 | $73K | 3.0% |
| 6 | $52.93 | 2,085 |
| $110K |
| 4.5% |
| Total | $52.15 avg | 47,152 | $2.5M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |